Clarivate Plc, a leading global provider of transformative intelligence, today unveiled its annual G20 scorecard, offering a comprehensive analysis of research and innovation capabilities across G20 members. Compiled by expert analysts and data scientists at the Institute for Scientific Information (ISI)™, this year's report introduces data for the European Union and the G20’s new permanent member, the African Union.
The G20 scorecard, featuring dynamic and interactive data visualizations, provides a responsible evaluation of the research and innovation landscape. It highlights collaborative impacts and demonstrates the societal effects of research and innovation, such as patent-to-paper citations. The scorecard also expands on analyses of research related to the UN Sustainable Development Goals (SDGs), underscoring the collaborative and accessible nature of this work. Released ahead of the G20 summit in Rio de Janeiro, Brazil on November 18-19, the report is freely available on Clarivate.com.
Key Findings of the 2024 G20 Scorecard:
• African Union (AU): Exhibits a high collaboration rate, with Mainland China collaborations yielding higher citation impacts than those with the U.S., its leading partner. The AU prioritizes SDG 1 (No Poverty) and SDG 5 (Gender Equality).
• European Union: The largest contributor of research papers among G20 members, with 40% of collaborations involving external partners compared to 10% within the EU. It publishes more open access papers than the G20 average.
• Germany: Boasts a high number of researchers per capita and an above-world-average Category Normalized Citation Impact™ (CNCI) for collaborative papers. Its Normalized Patent Citation Impact in Medicine is around twice the world average, with over 60% of papers produced in 2023 being open access.
• India: International collaboration has increased to just over one-third (35.6%) over the decade (2014 to 2023), with the U.S. being its leading collaborator. India's impactful SDG focus includes Economic Growth (SDG 8) and Industry (SDG 9).
• Mainland China: Predominantly engages in bilateral collaborations, with the U.S. being its most frequent partner despite a decline from 12% to 6% over the past decade. China's Normalized Patent Citation Impact is above the world average.
• South Korea: Collaborations with the U.S. have decreased, while those with Mainland China and India are on the rise. South Korea shows high Normalized Patent Citation Impact in SDG 3 (Good Health) and SDG 11 (Sustainable Cities), at 1.6 and 1.4 times the world average, respectively.
• United Kingdom: Research output has a high citation impact with a CNCI at 1.4 times the world average. Collaboration has risen from below 60% in 2015 to over 70% since 2022, with leading partners including the U.S., Germany, and increasingly, Mainland China. The UK's Normalized Patent Citation Impact is strong in Engineering and Technology, Medicine, and Life Sciences.
• United States: Exhibits high Normalized Patent Citation Impact in Engineering and Technology, Life Sciences, and Medicine. The U.S. has a strong focus on SDG 16 (Peace & Justice) and SDG 10 (Reduced Inequalities) in paper output, and on SDG 3 (Good Health) and SDG 7 (Clean Energy) in patent citation impact.
The 2024 G20 scorecard provides a valuable resource for understanding the global research and innovation landscape.
Click here to read the original press release.
